Pharmaceutical company Mallinckrodt agreed to pay approximately $260 million as part of a settlement announced Monday by the Department of Justice for underpaying Medicaid rebates and violating kickback laws regarding its drug Acthar.

Pharmaceutical company Mallinckrodt agreed to pay approximately $260 million as part of a settlement announced Monday by the Department of Justice for underpaying Medicaid rebates and violating kickback laws regarding its drug Acthar.